Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-25-072677·Abivax S.A.
Schedule 13D ownership disclosure
ABIVAX SA SPONSORED ADS
Ordinary Shares, par value (euro)0.01 per share · CUSIP: 00370M103
Event date: 2025-07-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sofinnova Crossover I SLPReported CIK 0001845105
Shares: 9,599,478.00 · Class: 11.4%
- Sofinnova Partners SASReported CIK 0001574139
Shares: 9,599,478.00 · Class: 11.4%
- Antoine PapiernikReported CIK 0001768408
Shares: 9,599,478.00 · Class: 11.4%
- Cedric Moreau
Shares: 9,599,478.00 · Class: 11.4%
- Kinam Hong
Shares: 9,599,478.00 · Class: 11.4%
- Joseph Anderson
Shares: 9,599,478.00 · Class: 11.4%
- Jacques Theurillat
Shares: 9,599,478.00 · Class: 11.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-072677
- Form type
- SCHEDULE 13D/A
- Filer
- Abivax S.A.
- CIK
- CIK 1956827
- Filed
- Jul 31, 2025
- Reporting period
- Jul 23, 2025
- Description
- Schedule 13D beneficial ownership